Hansa Biopharma AB
(OSTO:HNSA)
kr
52.75
3.45 (7%)
Market Cap: 3.57 Bil
Enterprise Value: 3.84 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 76/100 - Q2 2024 Hansa Biopharma AB Earnings Call TranscriptJul 18, 2024kr38.8 (-16.67%)Earnings
- Q1 2024 Hansa Biopharma AB Earnings Call TranscriptApr 18, 2024kr29.06 (-1.42%)Earnings
- Q4 2023 Hansa Biopharma AB Earnings Call TranscriptFeb 02, 2024kr31.32 (-7.88%)Earnings
- Hansa Biopharma AB Carlsquare Life Science Investor Day TranscriptDec 06, 2023
- Q3 2023 Hansa Biopharma AB Earnings Call TranscriptOct 26, 2023kr24.42 (-12.28%)Earnings
- Q2 2023 Hansa Biopharma AB Earnings Call TranscriptJul 20, 2023kr45.06 (+1.49%)Earnings
- Q1 2023 Hansa Biopharma AB Earnings Call TranscriptApr 20, 2023kr45.66 (-11.68%)Earnings
- Hansa Biopharma AB at TD Cowen Health Care Conference TranscriptMar 06, 2023
- Q4 2022 Hansa Biopharma AB Earnings Call TranscriptFeb 02, 2023kr53.5 (-12.94%)Earnings
- Nine months 2022 Hansa Biopharma AB Earnings Call TranscriptOct 20, 2022kr53.7 (-8.98%)Earnings
- Q2 2022 Hansa Biopharma AB Earnings Call TranscriptJul 19, 2022kr79 (+40.95%)Earnings
- Q1 2022 Hansa Biopharma AB Earnings Call TranscriptApr 21, 2022kr61.5 (+11.92%)Earnings
- Hansa Biopharma AB Erik Penser Bolagsdag Stockholm TranscriptMar 10, 2022
- Q4 2021 Hansa Biopharma AB Earnings Call TranscriptFeb 03, 2022kr63.8 (-15.09%)Earnings
- Hansa Biopharma AB Deep Dive: Gene Therapy Hosted by HC Andersen Capital TranscriptNov 05, 2021
- Hansa Biopharma AB Redeye Interview TranscriptOct 22, 2021
- Q3 2021 Hansa Biopharma AB Earnings Call TranscriptOct 21, 2021kr109.1 (+0.41%)Earnings
- Hansa Biopharma AB at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Hansa Biopharma AB Earnings Call TranscriptJul 15, 2021kr114.2 (-17.19%)Earnings
- Hansa Biopharma AB Redeye Orphan Drugs Event - Corporate Call TranscriptApr 28, 2021
- Q1 2021 Hansa Biopharma AB Earnings Call TranscriptApr 22, 2021kr179.1 (+12.29%)Earnings
- Full Year 2020 Hansa Biopharma AB Earnings Call TranscriptFeb 04, 2021kr181.5 (+0.55%)Earnings
- Hansa Biopharma AB at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Hansa Biopharma AB Corporate Analyst Meeting TranscriptOct 29, 2020
- Hansa Biopharma AB at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- Half Year 2020 Hansa Biopharma AB Earnings Call TranscriptJul 16, 2020kr252 (-2.55%)Earnings
- Hansa Biopharma AB (publ) - Special Call TranscriptJul 02, 2020
- Hansa Biopharma AB at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Q1 2020 Hansa Biopharma AB Earnings Call TranscriptApr 28, 2020kr121.1 (+5.49%)Earnings
- Q4 2019 Hansa Biopharma AB Earnings Call TranscriptFeb 06, 2020kr70.15 (-5.39%)Earnings
- Hansa Biopharma AB (publ) - Special Call TranscriptDec 13, 2019
- Nine Months 2019 Hansa Biopharma AB Earnings Call TranscriptOct 31, 2019kr128.5 (-8.93%)Earnings
- Hansa Biopharma AB at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Hansa Biopharma AB Earnings Call TranscriptJul 18, 2019kr172.9Earnings
- Hansa Biopharma AB at UBS Global Healthcare Conference TranscriptMay 20, 2019
- Q1 2019 Hansa Biopharma AB Earnings Call TranscriptApr 29, 2019Earnings
Hansa Biopharma AB at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019 / 05:30PM GMT
Release Date Price:
kr140.7
(-3.76%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Okay. Let's go ahead and get started. So hi, everyone. Thanks for being here. My name is Vikram Purohit. I'm one of the biotech analysts here at Morgan Stanley. And before we start our chat with Hansa, I just need to let everyone know that for all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, all of those appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures, or they're available at the registration desk. So with that, happy to have with me on the stage Hansa Biopharma CEO Søren Tulstrup. Welcome.
SÃ;ren Tulstrup;publ;President;CEO
Hansa Biopharma AB
¸ - ()-&
Thank you.
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Before we get into program and a company-specific Q&A, perhaps it's a good
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)